Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP64
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,379
Award facts
- Contract value 100% obligated
- $16,379.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,379.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, awarded on July 28, 2025, is scheduled for completion by August 18, 2025, with performance occurring at the vendor's Park Ridge facility. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.999 billion and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing prescription drugs and specialty medications to Department of Defense healthcare facilities nationwide. The company's core business involves distributing branded and generic pharmaceuticals, biologics, and medical consumables to military health systems. This delivery order for Keytruda, an oncology treatment, exemplifies the company's role in supplying specialized pharmaceutical products that support medical readiness across the defense healthcare enterprise. The award was made without a set-aside designation, allowing the woman-owned small business to compete on equal footing in the broader federal marketplace.
Quick answers
Who was awarded contract SPE2DB25FYP64?
SPE2DB25FYP64 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FYP64 worth?
The government has obligated $16,379 on SPE2DB25FYP64.
Is contract SPE2DB25FYP64 an order under another contract?
Yes. SPE2DB25FYP64 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP64 competed?
The extent of competition for SPE2DB25FYP64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award